Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$0.29 - $0.64 $1,533 - $3,383
-5,287 Reduced 6.87%
71,685 $21,000
Q4 2022

Feb 14, 2023

SELL
$0.38 - $22.5 $62,993 - $3.73 Million
-165,772 Reduced 68.29%
76,972 $30,000
Q3 2022

Nov 18, 2022

SELL
$0.73 - $23.4 $3,396 - $108,880
-4,653 Reduced 1.88%
242,744 $171,000
Q2 2022

Aug 15, 2022

BUY
$0.66 - $1.81 $4,057 - $11,126
6,147 Added 2.55%
247,397 $200,000
Q1 2022

May 16, 2022

SELL
$1.27 - $2.47 $17,037 - $33,135
-13,415 Reduced 5.27%
241,250 $400,000
Q4 2021

Feb 15, 2022

BUY
$2.21 - $3.22 $18,972 - $27,643
8,585 Added 3.49%
254,665 $596,000
Q3 2021

Nov 15, 2021

SELL
$2.8 - $3.72 $30,472 - $40,484
-10,883 Reduced 4.24%
246,080 $765,000
Q2 2021

Aug 16, 2021

SELL
$2.61 - $4.17 $38,554 - $61,599
-14,772 Reduced 5.44%
256,963 $861,000
Q1 2021

May 18, 2021

SELL
$2.91 - $4.32 $2,383 - $3,538
-819 Reduced 0.3%
271,735 $845,000
Q4 2020

Feb 16, 2021

BUY
$2.15 - $3.5 $24,759 - $40,306
11,516 Added 4.41%
272,554 $750,000
Q3 2020

Nov 17, 2020

BUY
$2.77 - $6.17 $5,919 - $13,185
2,137 Added 0.83%
261,038 $747,000
Q2 2020

Aug 17, 2020

BUY
$0.87 - $3.13 $22,732 - $81,783
26,129 Added 11.23%
258,901 $803,000
Q1 2020

May 13, 2020

SELL
$0.73 - $1.91 $842 - $2,204
-1,154 Reduced 0.49%
232,772 $221,000
Q4 2019

Feb 14, 2020

BUY
$0.48 - $1.38 $50,274 - $144,538
104,738 Added 81.07%
233,926 $323,000
Q2 2019

Aug 14, 2019

BUY
$0.65 - $2.12 $83,972 - $273,878
129,188 New
129,188 $151,000
Q2 2018

Aug 14, 2018

SELL
$2.75 - $3.85 $146,720 - $205,409
-53,353 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$3.5 - $4.47 $3,874 - $4,948
-1,107 Reduced 2.03%
53,353 $187,000
Q4 2017

Feb 14, 2018

BUY
$3.29 - $5.03 $61,720 - $94,362
18,760 Added 52.55%
54,460 $233,000
Q3 2017

Nov 13, 2017

BUY
$3.15 - $4.01 $112,455 - $143,157
35,700
35,700 $137,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.